 |
Click Here to Find Out the Holistic Guide to Combat Chronic Fatigue and Fibromyalgia |
Managing
Fibromyalgia Pain and Depression - Cymbalta Fibromyalgia Treatments for
Depression
Cymbalta,
which is an antidepressant, is believed to reduce depression and is also considered to be a
possible benefit to women suffering from Fibromyalgia. This illness, which is still
considered rare even though it affects millions of Americans, affects more
women and men. Even though the cause of it remains unknown, Fibromyalgia is a growing problem that many are
forced to cope with on a daily basis.
A
Cymbalta Fibromyalgia treatment is designed to help treat
both the emotional and physical symptoms of depression. In general, individuals who are
dealing with a chronic illness often become depressed and sometimes turn to the world
of medicine for assistance.
It
is important to note that Cymbalta is not approved for the treatment of Fibromyalgia, but studies have found that it could
be beneficial in depression. Because it is thought to help treat depression, which is often the result
of a chronic illness, some experts believe that there are benefits that
coincide with this illness and a Cymbalta Fibromyalgia treatment.
Cymbalta
Fibromyalgia treatments can cause various side effects with the most common
being nausea, constipation, dry mouth, decreased appetite, etc.
Cymbalta is not for everyone, especially to those who are allergic to its
ingredients.
In
addition, individuals with liver or kidney problems, have been diagnosed with glaucoma
or consume large amounts of alcohol should speak with their physician prior to
taking Cymbalta. Women who are pregnant or nursing should not take Cymbalta and
should make their physician aware of any conditions prior to accepting any type
of prescription.
Prior
to accepting any type of prescription medication, individuals must make sure
that their physician is made fully aware of any medicines that are currently
being consumed and/or any current illnesses. In order to safely provide
treatments, a physician must be made fully aware of the circumstances
surrounding the patient's health.
Patients
who are being treated for depression should be monitored closely in order to
ensure that the depression does not worsen or become increasingly
dangerous to the patient. Individuals who are severely depressed may require
hospitalization and extended care beyond that which a prescription-based
medicine can offer. Anyone who feels that their depression is worsening should consult their
physician for a proper diagnosis and a recommended treatment course.
Managing
Fibromyalgia Pain and Depression - Lyrica for Fibromyalgia
Lyrica,
also known as pregabalin derived from a prohibited neurotransmitter,
gamma-aminobutyric acid (GABA).
Lyrica
has been standardised by the FDA for diabetic nerve ache and post-therapeutic
nerve ache. Lyrica connects to calcium path in the central nervous system. Its
outcome is realised due to its ability to trim down the calcium dependent
release of several neurotransmitters.
Researchers
at the University of Michigan assessed the efficiency and security of
pregabalin for the treatment of fibromyalgia (FM) in an eight-week,
placebo-controlled, phase II test. The patients were given with pregabalin
doses of 150mg, 300mg, or 450mg per day or with a placebo.
The
total dosage was fragmented into three doses a day and consumed for eight
weeks. After a one-week baseline-watching period, the primary measurement of
efficiency was the pain level at the end of the eight weeks. This information
was taken from daily ache diaries.
Patients
treated with Lyrica had statistically momentous improvement in their average
pain score contrasted with the placebo. The patients who are treated with Lyrica,
28.9 percent had a statistically noteworthy (greater than 50 percent) drop in
pain from baseline matched up to 13.2 percent of patients treated with the
placebo.
Forty-eight
percent of patients in the Lyrica of the 450mg per day group had at least a 30
percent statistically momentous fall in pain from baseline compared to 27
percent on the placebo. The significant progress in pain happened as early as
week one.
There
were major improvements in practical ways such as sleep, fatigue, and activity of life. The most common
treatment events were drowsiness and faintness and were considered to be dose
related. Discontinuous rates owed to side effects were less than 10 percent.
Fibromyalgia
experts have used Lyrica in practice and more medical information regarding its
effect on Fibromyalgia is yet to come out.
The
information in this article is to be used for informational purposes only. It
should not be used in place of, or in conjunction with, professional medical
advice. Anyone with questions regarding a Cymbalta Fibromyalgia treatment or Lyrica
for fibromyalgia must consult their physician for further information.
For
more ideas on managing fibromyalgia pain and depression, watch these 2 videos-
This
article is from the Get Your Health Back – Fibromyalgia & Chronic Fatigue Freedom.
It consists of a strategy filled with guides on sleep, pain, depression,
anxiety, diet, exercise and fitness plans, diet plans and packed with 369
healthy and delicious recipes
To
find out more about this program, visit the website - Get Your Health Back – Fibromyalgia & Chronic Fatigue Freedom
No comments:
Post a Comment